To find out whether a high number of auto-antibodies can increase the probability of a "good-EULAR response" and to identify the possible biomarkers of response in seropositive rheumatoid arthritis (RA) patients undergoing the B cell depletion therapy (BCDT).
Ferraccioli, G., Tolusso, B., Bobbio Pallavicini, F., Gremese, E., Ravagnani, V., Benucci, M., Podestà, E., Atzeni, F., Mannocci, A., Biasi, D., Manfredi, M., Sarzi Puttini, P., Laganà, B., Montecucco, C., Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis, <<PLOS ONE>>, 2012; 7 (7): e40362-e40369. [doi:10.1371/journal.pone.0040362] [http://hdl.handle.net/10807/31456]
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis
Ferraccioli, Gianfranco;Tolusso, Barbara;Gremese, Elisa;Mannocci, Alice;
2012
Abstract
To find out whether a high number of auto-antibodies can increase the probability of a "good-EULAR response" and to identify the possible biomarkers of response in seropositive rheumatoid arthritis (RA) patients undergoing the B cell depletion therapy (BCDT).
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream--3778596.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
129.7 kB
Formato
Adobe PDF
|
129.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
